Tani N, Kataoka N, Kunimatsu Y, et al. Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study. Multidiscip Respir Med. 2021;16. doi:10.4081/mrm.2021.736